ITGAX and neoplasm: Flowcytometry revealed significantly higherCD103+CD11c+ DCs(Fig. 4a) and elevatedPD-1+ andCD69+CD62L−CD8+TILs (Fig. 4b), in the tumours from STINGagonist-treated mice.